ABSTRACT
Acanthamoeba keratitis (AK) is a rare, sight-threating corneal infection. The disease is challenging to diagnose and treat, and the amoeba can rapidly encyst, persisting in the tissue and causing recurrences. Medical therapy is conventionally considered the first line treatment, but advanced cases could require more invasive treatments like a "chaud" corneal transplant. We review the incidence of severe complications in patients affected byAK. Of 439 reports screened, 158 met our inclusion criteria. Incidence of severe complications was low, with 2.21% patients developing perforation, 1% requiring evisceration/enucleation and less than 1% developing endophthalmitis. Corneal transplantation was required in 16.68% of the cases. According to our results, and considering the reported incidences of these complications in other infectious keratitis, AK patients have an overall low risk of developing perforation, endophthalmitis, and enucleation/evisceration. Nevertheless, data available in literature remain poor, and further randomized control trials are needed to confirm our findings.
